Concentrations of pefloxacin in plasma and tissue after administration as surgical prophylaxis

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 2, 1998, Pages 425-427

  Jacoberger, Bernadette ^a   Ubeaud, Genevieve ^b   Freys, Guy ^a   Pottecher, Thierry ^a   Jung, Louis ^b   Koffel, Jean Claude ^a,b  

^a HÔPITAL DE HAUTEPIERRE   (France)

^b University of Pharmacy   (France)

Author keywords

[No Author keywords available]

Indexed keywords

NORFLOXACIN; PEFLOXACIN;

ADIPOSE TISSUE; ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; COLORECTAL SURGERY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG PENETRATION; DRUG TISSUE LEVEL; ENTEROBACTERIACEAE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; POSTOPERATIVE INFECTION; PRIORITY JOURNAL;

ADULT; AGED; ANTI-INFECTIVE AGENTS; ANTIBIOTIC PROPHYLAXIS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENTEROBACTERIACEAE; FEMALE; HUMANS; MALE; MIDDLE AGED; PEFLOXACIN; REPRODUCIBILITY OF RESULTS;

EID: 0031894329     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Auckenthaler, R., M. Michea-Hamzehpour, and J. C. Pechere. 1986. In-vitro activity of newer quinolones against aerobic bacteria. J. Antimicrob. Chemother. 17(Suppl. E):29-39.
2. Barre, J., G. Houin, and J. P. Tillement. 1984. Dose-dependent pharmacokinetic study of pefloxacin, a new antibacterial agent, in humans. J. Pharm. Sci. 73:1379-1382.
3. Bergamini, T. H., and M. C. Polk. 1989. The importance of tissue antibiotic activity in the prevention of operative wound infection. J. Antimicrob. Chemother. 23:301-313.
4. Bergan, T. 1988. Pharmacokinetics of fluorinated quinolones, p. 119-154. In T. V. Andriole (ed.). The quinolones. Yale University School of Medicine, New Haven, Conn.
5. Classen, D. C., R. S. Evans, S. L. Pestotnik, S. D. Horn, R. L. Menlove, and J. P. Burke. 1992. The timing of prophylaxie administration of antibiotics and the risk of surgical wound infection. N. Engl. J. Med. 326:281-286.
6. Daschner, F. D., M. Westenfelder, and A. Dalhoff. 1986. Penetration of ciprofloxacin into kidney, fat, muscle and tissue. Eur. J. Clin. Microbiol. 5:212-213.
7. Drusano, G. L. 1989. Pharmacokinetics of the quinolone antimicrobial agents, p. 71-105. In J. S. Wolfson and D. C. Hooper (ed.), Quinolone antimicrobial agents. American Society for Microbiology, Washington, D.C.
8. Frydman, A. M., Y. Le Roux, M. A. Lefevre, F. Djebbar, J. B. Fourtillan, and J. Gaillot. 1986. Pharmacokinetics of pefloxacin after repeated intravenous and oral administration (400 mg bid) in young healthy volunteers. J. Antimicrob. Chemother. 17(Suppl. E):65-79.
9. Kaiser, A. B. 1986. Antimicrobial prophylaxis in surgery. N. Engl. J. Med. 315:1129-1138.
10. King, A., and I. Phillips. 1986. The comparative in-vitro activity of pefloxacin. J. Antimicrob. Chemother. 17(Suppl. E):1-10.
11. Stone, H. H. 1984. Basic principles in the use of prophylactic antibiotics. J. Antimicrob. Chemother. 14(Suppl. B):33-37.